Overall, our findings point to a potentially altered response of advanced MDS patients to cell cycle and apoptotic mediators, specially among non-lymphoid (uncommitted plus myeloid) CD34+, NRBC and immature neutrophil precursors, whereas the more mature neutrophils might retain residual susceptibility to such proliferation stimuli. Here, CD34 is linked to myelodysplastic syndrome.